The bcr-abl fusion gene encodes a 210-kDa hybrid protein known as P210bcr/abl, which has strong tyrosine kinase activity, and is deemed to play a critical role in tumorigenesis of CML [3, 4]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.